Literature DB >> 16564579

A statistical method for comparing viral growth curves.

Gary P Wang1, Frederic D Bushman.   

Abstract

Viral replication is often analyzed by growth curves, in which viral multiplication in the presence of host cells is measured as a function of time. Comparing growth curves is one of the most sensitive ways of comparing viral growth under different conditions or for comparing replication of different viral mutants. However, such experiments are rarely analyzed in a statistically rigorous fashion. Here a statistical method is described for comparing curves, using replication of HIV in the presence of an integrase inhibitor as an example. A complication in the analysis arises due to the fact that sequential measurements of virus accumulation are not independent, which constrains the choice of statistical method. In the recommended approach, the values for virus accumulation over time are fitted to an exponential equation, then the means of the extracted growth rates compared using a nonparametric test, either the Mann-Whitney U-test for two samples or the Kruskal-Wallis test for multiple samples. A web-based tutorial for implementing this method is available at http://microb230.med.upenn.edu/tutorials/wangTutorial.

Mesh:

Substances:

Year:  2006        PMID: 16564579     DOI: 10.1016/j.jviromet.2006.02.008

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  15 in total

1.  Replicative capacity differences of thymidine analog resistance mutations in subtype B and C human immunodeficiency virus type 1.

Authors:  Kimberly L Armstrong; Tun-Hou Lee; M Essex
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

2.  Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid.

Authors:  Parvez M Lokhandwala; Tam-Linh N Nguyen; J Bradford Bowzard; Rebecca C Craven
Journal:  Virology       Date:  2008-04-22       Impact factor: 3.616

3.  Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis.

Authors:  Nicola Richardson-Harman; Carol Lackman-Smith; Patricia S Fletcher; Peter A Anton; James W Bremer; Charlene S Dezzutti; Julie Elliott; Jean-Charles Grivel; Patricia Guenthner; Phalguni Gupta; Maureen Jones; Nell S Lurain; Leonid B Margolis; Swarna Mohan; Deena Ratner; Patricia Reichelderfer; Paula Roberts; Robin J Shattock; James E Cummins
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948

4.  Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.

Authors:  Katrina J Heyrana; Boon Chong Goh; Juan R Perilla; Tam-Linh N Nguyen; Matthew R England; Maria C Bewley; Klaus Schulten; Rebecca C Craven
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

5.  Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest.

Authors:  Zhiqiang Xu; Neel Joshi; Ashima Agarwal; Sonika Dahiya; Patrice Bittner; Erin Smith; Sara Taylor; David Piwnica-Worms; Jason Weber; Jeffrey R Leonard
Journal:  J Neurooncol       Date:  2012-03-01       Impact factor: 4.130

6.  STING-dependent translation inhibition restricts RNA virus replication.

Authors:  Kate M Franz; William J Neidermyer; Yee-Joo Tan; Sean P J Whelan; Jonathan C Kagan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

7.  A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo.

Authors:  D Bailey; L B Thackray; I G Goodfellow
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

8.  Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.

Authors:  Don B Gammon; Robert Snoeck; Pierre Fiten; Marcela Krecmerová; Antonín Holý; Erik De Clercq; Ghislain Opdenakker; David H Evans; Graciela Andrei
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

9.  Human MicroRNA miR-532-5p Exhibits Antiviral Activity against West Nile Virus via Suppression of Host Genes SESTD1 and TAB3 Required for Virus Replication.

Authors:  Andrii Slonchak; Rory P Shannon; Gabor Pali; Alexander A Khromykh
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

10.  Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells.

Authors:  Armand Paauw; Maurine A Leverstein-van Hall; Kok P M van Kessel; Jan Verhoef; Ad C Fluit
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.